Recombinant Anti-BCMA x Anti-TACI Bispecific Antibody (Minibody) is designed to be expressed as the anti-BCMA scFv fused to N-terminus of Knob-CH3 domain and the anti-TACI scFv to the Hole-CH3 domain, or vice versa. The CH3 domains are further stabilized by C-terminal disulfide bonds. This BsAb can bind two receptors simultaneously. It is designed for the research of Lymphoma therapy.
There are currently no customer reviews or questions for Recombinant Anti-BCMA x Anti-TACI Bispecific Antibody (Minibody) (MiniB-021). Click the button below to contact us or submit your feedback about this product.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS